Minnesota grapples with promise of COVID-19 drug in limited supply, unknown cost

This round of medication is on the house. The next one will be, too.

But eventually, California's Gilead Sciences will start charging Americans for remdesivir, the drug that recently became the only therapeutic agent shown to cut down the recovery from COVID-19.

https://www.startribune.com/minnesota-grapples-with-promise-of-covid-19-drug-in-limited-supply-unknown-cost/570549072/